Ledger.Open graph →
SEC Form D · filed April 14, 2022

Ansa Biotechnologies, Inc

Offering
$76.7M
Sold
$67.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Sebastian T. Palluk · Emeryville, CAExec · DirectorDaniel T. Lin-Arlow · Emeryville, CAExec · DirectorLily Li · Emeryville, CADirectorRicardo Repenning · Cambridge, MADirectorRichard Chesney · Dallas, TXExec · DirectorYmir Vigfusson · DOVER, DEExec · DirectorNewton Howard · FRISCO, TXExec · DirectorRobert V. Delaney, Jr · New York, NYExec · DirectorBrian P. Cassidy · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗